Targeting CV risk factors with GLP-1 RAs in people with obesity - report from EASD2022

from Medical Digest & Congress Report · host Medical Congress News

Professor Michael Lincoff shares with us a discussion occurred during the EASD 2022 meeting, this was focusing on the modification of cardiovascular risk in patients with obesity with the GLP-1 receptor agonists. Video: https://congressreport.eu/scientific-contents/interview:targeting-cv-risk-factors-glp-1-ras-people-obesity

Episode metadata supplied by the publisher feed · Published Oct 18, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Targeting CV risk factors with GLP-1 RAs in people with obesity - report from EASD2022

0:00 9:22

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 9 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on October 18, 2022.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!